Till Uhlig
Utdanning
- Dr. Med ved det medisinske fakultet, Universitet i Oslo (1996)
- Spesialist i revmatologi (2000)
- Doktorgrad ved det medisinske fakultet, Universitetet i Oslo
Stilling
- Seksjonsoverlege/Seniorforsker ved Klinikk for revmatologi, poliklinikk og forskning, Diakonhjemmet sykehus
- Professor II ved Institutt for klinisk medisin, Universitetet i Oslo
Interessefelt
- Klinisk revmatologi
- Urinsyregikt
- Revmatoid artritt
- Artrose
- Rehabilitering
Annet
- Leder av arbeidspakke 6 i REMEDY (Langtidsoppfølging)
E-post
Besøksadresse
Diakonhjemmet sykehus
Forstanderboligen
Reidar Kobros vei 8
0370 Oslo
Postadresse
Diakohjemmet sykehus
Postboks 23 Vinderen
0319 Oslo
Prosjekter
ARCTIC
Remisjon hos pasienter med revmatoid artritt: en randomisert kontrollert studie som undersøker bruk av ultralyd i klinisk oppfølging
Prosjektleder:
Espen A. HaavardsholmProsjektleder:
Sella Aarrestad ProvanNORD-STAR
Den nordiske studien av strategiprøver og registre for revmatiske sykdommer
Prosjektleder:
Espen A. HaavardsholmRehabNytte
Spesialisert rehabilitering ved private rehabiliteringsinstitusjoner
Prosjektleder:
Rikke Helene MoeProsjektleder:
Till UhligReMonit Gout
Digital hjemmeoppfølging og mestring av urinsyregikt
Prosjektleder:
Nina ØsteråsPublikasjoner
Publikasjoner hentet fra Nasjonalt vitenarkiv (NVA):
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
The Lancet Rheumatology
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis
Arthritis Research & Therapy
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial
Annals of the Rheumatic Diseases
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials
RMD Open
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Annals of the Rheumatic Diseases
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Annals of the Rheumatic Diseases
Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomised controlled trial
The Lancet Rheumatology
Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study
RMD Open
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.
Arthritis Research & Therapy
Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
Annals of the Rheumatic Diseases
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: Achievements of the urate target levels and predictors of obtaining this target
RMD Open
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients with Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
Journal of the American Medical Association (JAMA)
Validity and diagnostic performance of fluorescence optical imaging measuring synovitis in hand osteoarthritis: baseline results from the Nor-Hand cohort
Arthritis Research & Therapy
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: Phase IV investigator initiated, randomised, observer blinded clinical trial
The BMJ
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries
Annals of the Rheumatic Diseases
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Annals of the Rheumatic Diseases
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis
Clinical Rheumatology
Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.
Annals of the Rheumatic Diseases
Swollen, but not tender joints, are independently associated with ultrasound synovitis: Results from a longitudinal observational study of patients with established rheumatoid arthritis
Annals of the Rheumatic Diseases
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
RMD Open
The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: Secondary analyses from a randomized trial examining the benefit of ultrasound in a clinical tight control regimen
Arthritis & Rheumatology
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: Associations to future good radiographic and physical outcomes
Annals of the Rheumatic Diseases
Health-related quality of life in patients with psoriatic and rheumatoid arthritis: Data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls
Annals of the Rheumatic Diseases
The eumusc.net standards of care for rheumatoid arthritis: Importance and current implementation according to patients and healthcare providers in the Netherlands
Clinical and Experimental Rheumatology
Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: Study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study
Trials
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria
Annals of the Rheumatic Diseases
Calcium supplementation and inflammation increase mortality in rheumatoid arthritis: A 15-year cohort study in 609 patients from the Oslo Rheumatoid Arthritis Register
Seminars in Arthritis & Rheumatism
Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD
Rheumatology